X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

VIRI

Closed

Virios Therapeutics Llc

0.178
0.000 (0.00%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 0.178
Day's Range: 0.17 - 0.1872
Send
When Written:
 
0.53
Virios Therapeutics LLC is a clinical-stage biotechnology company that focuses on the development of novel therapies for rare diseases. The company's lead product candidate, IMC-1, is a combination of famciclovir and celecoxib that is being developed for the treatment of fibromyalgia.

Virios was founded in 2017 and is headquartered in Rockville, Maryland. The company's management team has extensive experience in drug development and commercialization.

In addition to IMC-1, Virios is also developing other product candidates for the treatment of rare diseases. The company's mission is to improve the lives of patients with unmet medical needs by developing innovative therapies.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:18.224.32.230
X